(Press-News.org) Using a generic drug to treat hypertension and heart failure, instead of branded medicines from the same class, could save the UK National Health Service (NHS) at least £200 million in 2011 without any real reduction in clinical benefits.
That is the key finding of a systematic review, statistical meta-analysis and cost-effectiveness analysis just published online by IJCP, the International Journal of Clinical Practice.
Researchers from University College London Hospitals NHS Foundation Trust looked at 14 hypertension and heart studies published between 1998 and 2009 on 16,179 patients. Just over two-thirds of the patients were male (68 per cent), with an average age of 60 years.
They set out to compare the clinical benefits and cost-effectiveness of using the market leader candesartan instead of generic losartan, which is now considerably cheaper.
"When drugs are first launched they are protected by patents and relatively expensive as the pharmaceutical companies need to recover their research and development costs" explains lead author Dr Anthony Grosso.
"Once these patents have expired, the manufacturer loses market exclusivity and generic drugs can be produced, which ultimately drives down the price. This offers significant opportunities for cost savings, but only if the clinical evidence supports the use of the less expensive generic drugs."
The NHS currently spends more than £250 million a year on angiotensin-II receptor blockers (ARB) for high blood pressure and heart failure, with candesartan - which is still under patent and marketed under a number of brand names - currently dominating the market.
"Our comparative research showed that candesartan reduced blood pressure slightly more than losartan, with diastolic readings averaging 2mmHg lower and systolic readings 3mmHg lower" says Dr Grosso. "However, this difference is unlikely to be cost effective, particularly when it is prescribed in combination with other drugs.
"When we took all the factors into account, based on the evidence we reviewed, it was clear that losartan was likely to be the most cost-effective ARB to treat high blood pressure or heart failure."
The authors estimate that using generic losartan as the angiotensin-II receptor blocker of choice could save the NHS approximately £200 million in 2011. "This figure is based on 2009 prescribing figures for primary care alone, so the actual savings could be even higher" says Dr Grosso.
In an accompanying editorial, Dr Rubin Minhas, Clinical Director & Editor-in-Chief of the BMJ Evidence Centre, stresses the need for the NHS to achieve clinically effective cost savings against a background of stringent public sector cuts and proposed NHS reforms.
He points out that the findings by Grosso et al come hard on the heels of the report by the York Health Economics Consortium in November 2010. This found that £300 million worth of medicine was discarded for various reasons in primary and community care rather than being taken by patients.
"NHS prescribing is a complex issue and it is vital that the proposed changes to the NHS ensure that doctors are making high-quality clinical decisions that are also cost-effective" says Dr Minhas. "It is a delicate balancing act between what doctors think are best for their patients and making the best use of hard-pressed budgets. That is why reviews like this are so important."
A further editorial by US commentators Dr Bertram Pitt and Dr Stevo Julius, from the University of Michigan School of Medicine, has welcomed the findings but stressed the need for further research.
They say it is particularly important to see further data on comparable cardiovascular benefits in patients with hypertension and/or heart failure before switching patients from candesartan to losartan. This will ensure that clinicians are not trading short-term savings for a long-term, more expensive increase in cardiovascular risks.
INFORMATION:
The paper and the two editorials can be viewed free online at:
http://onlinelibrary.wiley.com/doi/10.1111/j.1742-1241.2011.02633.x/pdf
http://onlinelibrary.wiley.com/doi/10.1111/j.1742-1241.2011.02646.x/pdf
http://onlinelibrary.wiley.com/doi/10.1111/j.1742-1241.2011.02642.x/pdf
Note to editors:
Paper: Comparative clinical- and cost-effectiveness of candesartan and losartan in the management of hypertension and heart failure: a systematic review, meta- and cost-utility analysis. Grosso et al. IJCP. Published online early in advance of publication in the March issue. DOI: 10.1111/j.1742-1241.2011.02633.x
Editorial: Waste not, want not: free money, moral hazard and value-based prescribing. Minhas R. IJCP. Published online early in advance of publication in the March issue.
DOI: 10.1111/j.1742-1241.2011.02646.x
Editorial: Easy money?: Health cost savings resulting from the switch from a branded drug to a low-cost generic drug in the same class. Pitt B and Julius S. IJCP. Published online early in advance of publication in the March issue.
DOI: 10.1111/j.1742-1241.2011.02642.x
IJCP, the International Journal of Clinical Practice was established in 1946 and is edited by Dr Graham Jackson. It provides its global audience of clinicians with high-calibre clinical papers, including original data from clinical investigations, evidence-based analysis and discussions on the latest clinical topics. The journal is published by Blackwell Publishing Ltd, part of the international Blackwell Publishing group. www.ijcp.org www.twitter.com/IJCPeditors
Wiley-Blackwell is the international scientific, technical, medical, and scholarly publishing business of John Wiley & Sons, with strengths in every major academic and professional field and partnerships with many of the world's leading societies. Wiley-Blackwell publishes nearly 1,500 peer-reviewed journals and 1,500+ new books annually in print and online, as well as databases, major reference works and laboratory protocols. For more information, please visit http://www.wileyblackwell.com/ or our new online platform, Wiley Online Library (http://www.wileyonlinelibrary.com/), one of the world's most extensive multidisciplinary collections of online resources, covering life, health, social and physical sciences, and humanities.
END
The genes that make up the human genome were mapped by HUGO, the Human Genome Organisation, and published in 2001. Now the project is expanding into the HUPO, the Human Proteome Organisation. Within the framework of this organisation, many hundreds of researchers around the world will work together to identify the proteins that the different genes give rise to in the human body.
"The 'proteome', the set of all human proteins, is significantly more complicated than the genome. There are over 20 000 proteins coded by the genome in the human body and each protein can have ...
Up to seven per cent biodiesel blended in regular diesel will presumably not cause greater health risks for the population than the use of pure fossil diesel. This is the main conclusion in a memorandum from the Norwegian Institute of Public Health and the Climate and Pollution Control Agency (formerly SFT) to the Ministry of Health and Care Services and the Ministry of the Environment in Norway.
"A higher content of biodiesel (up to 20 per cent) requires more research to assess health effects. This must include different types of biofuels and blending ratios, as well ...
University of Manchester scientists have shown that a protein involved in blood clotting can be used to diagnose and subsequently monitor the treatment of a group of childhood genetic diseases.
In the study, published in the Journal of Inherited Metabolic Disease, the researchers were able to show that the clotting agent, heparan cofactor II/Thrombin (HCII/T) complex, could be used as a 'biomarker', or biological tell, in individuals with mucopolysaccharide (MPS) diseases.
MPS diseases are severe metabolic conditions caused by a genetic defect that affects the body's ...
University of Granada scientists have been the first to analyze the relation between drug abuse and recognition of basic emotions (happiness, surprise, wrath, fear, sadness and disgust) by drug-abusers. Thus, the study revealed that drug-abusers have difficulty to identify negative emotions by their facial expression: wrath, disgust, fear and sadness.
Further, regular abuse of alcohol, cannabis and cocaine usually affects abusers' fluency and decision-making. Consuming cannabis and cocaine negatively affects work memory and reasoning. Similarly, cocaine abuse is associated ...
Pacific Northwest farmers could someday be filling up their machinery's tanks with fuels produced from their own fields, according to ongoing research by U.S. Department of Agriculture (USDA) scientists.
Since 2003, Agricultural Research Service (ARS) microbiologist Hal Collins and agronomist Rick Boydston have been studying safflower, camelina, soybeans, mustard, canola, wheat, corn and switchgrass to assess their potential for bioenergy production. ARS is USDA's chief intramural scientific research agency, and this research supports the USDA priority of developing ...
Moving to a new country is difficult—learning the cultural rules and meanings of your new home is especially challenging. A new study published in Psychological Science, a journal of the Association for Psychological Science, finds that this process is easier for children, but quickly becomes more difficult after about the age of 15.
Psychological scientists have found that many aspects of learning and development have a critical window—if a developmental event doesn't happen by a particular age, it never will. For example, learning perfect pitch or learning to see with ...
Camden, N.J., February 3, 2011– Studies show drinking V8® 100% vegetable juice may be a simple way for people to increase their vegetable intake and may help them manage their weight – two areas of concern outlined in the newly released 2010 U.S. Dietary Guidelines for Americans.1
A study conducted by researchers at the University of California-Davis found that adults who drank one, 8-ounce glass of vegetable juice each day, as part of a calorie-appropriate Dietary Approaches to Stop Hypertension (DASH) diet, got nearly twice as many vegetable servings a day than those ...
CHAMPAIGN, Ill. — Researchers have discovered the 100 million-year-old ancestor of a group of large, carnivorous, cricket-like insects that still live today in southern Asia, northern Indochina and Africa. The new find, in a limestone fossil bed in northeastern Brazil, corrects the mistaken classification of another fossil of this type and reveals that the genus has undergone very little evolutionary change since the Early Cretaceous Period, a time of dinosaurs just before the breakup of the supercontinent Gondwana.
The findings are described in a paper in the open access ...
MBL, WOODS HOLE, MA—The ubiquitous freshwater "water flea," Daphnia pulex, may be too small to see, but it has amply proven its value as an "sentinel species" for the presence of toxins and pollutants in the environment.
Daphnia's response to exposure to toxic metals and other chemical pollutants is well studied, and this information is routinely used by groups such as the US Environmental Protection Agency (EPA) to define regulatory limits, and to monitor industrial and municipal discharges.
This week, Daphnia pulex is receiving an enormous pat on the back from the ...
Earth observation scientists at the University of Leicester have recorded stunning images of tropical cyclone Yasi by orbiting satellites.
Japanese Meteorological Agency and European Space Agency satellite instruments have been observing the intense storm over Australia from their vantage points in space.
University of Leicester scientists have used two instruments, MTSAT-2 and MERIS, which have enabled the scientists to follow the progress of the storm as it headed towards and then struck the Australian coast. They have provided unique views from space of a storm ...
